nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—esophageal cancer	0.529	1	CbGaD
Zafirlukast—ABCG2—Carboplatin—esophageal cancer	0.0837	0.298	CbGbCtD
Zafirlukast—ABCG2—Cisplatin—esophageal cancer	0.0715	0.255	CbGbCtD
Zafirlukast—CYP2C9—Capecitabine—esophageal cancer	0.0528	0.188	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—esophageal cancer	0.0464	0.165	CbGbCtD
Zafirlukast—CYP2C9—Cisplatin—esophageal cancer	0.0266	0.0946	CbGbCtD
Zafirlukast—Tolvaptan—ABCB1—esophageal cancer	0.00128	0.471	CrCbGaD
Zafirlukast—Hepatotoxicity—Cisplatin—esophageal cancer	0.00118	0.0259	CcSEcCtD
Zafirlukast—Infection—Carboplatin—esophageal cancer	0.0011	0.0241	CcSEcCtD
Zafirlukast—Raised liver function tests—Methotrexate—esophageal cancer	0.00108	0.0237	CcSEcCtD
Zafirlukast—Liver injury—Cisplatin—esophageal cancer	0.00108	0.0237	CcSEcCtD
Zafirlukast—Glyburide—ABCC2—esophageal cancer	0.00105	0.387	CrCbGaD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.00102	0.0223	CcSEcCtD
Zafirlukast—Haematemesis—Capecitabine—esophageal cancer	0.000967	0.0212	CcSEcCtD
Zafirlukast—Pain—Carboplatin—esophageal cancer	0.000948	0.0208	CcSEcCtD
Zafirlukast—Throat sore—Capecitabine—esophageal cancer	0.000932	0.0204	CcSEcCtD
Zafirlukast—Blister—Capecitabine—esophageal cancer	0.000932	0.0204	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000924	0.0202	CcSEcCtD
Zafirlukast—Haemoptysis—Capecitabine—esophageal cancer	0.000908	0.0199	CcSEcCtD
Zafirlukast—Body temperature increased—Carboplatin—esophageal cancer	0.000876	0.0192	CcSEcCtD
Zafirlukast—Hepatotoxicity—Capecitabine—esophageal cancer	0.00087	0.0191	CcSEcCtD
Zafirlukast—CYSLTR2—lung—esophageal cancer	0.00086	0.22	CbGeAlD
Zafirlukast—Neuropathy—Cisplatin—esophageal cancer	0.000856	0.0187	CcSEcCtD
Zafirlukast—Contusion—Capecitabine—esophageal cancer	0.00077	0.0169	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000744	0.0163	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000739	0.0162	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000739	0.0162	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—esophageal cancer	0.00072	0.0158	CcSEcCtD
Zafirlukast—Influenza like illness—Capecitabine—esophageal cancer	0.000652	0.0143	CcSEcCtD
Zafirlukast—Hepatotoxicity—Methotrexate—esophageal cancer	0.000648	0.0142	CcSEcCtD
Zafirlukast—Neuropathy—Capecitabine—esophageal cancer	0.000631	0.0138	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000558	0.0122	CcSEcCtD
Zafirlukast—Swelling—Capecitabine—esophageal cancer	0.000553	0.0121	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00055	0.012	CcSEcCtD
Zafirlukast—Abdominal discomfort—Cisplatin—esophageal cancer	0.000548	0.012	CcSEcCtD
Zafirlukast—Hepatic failure—Capecitabine—esophageal cancer	0.000543	0.0119	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—esophageal cancer	0.000512	0.0112	CcSEcCtD
Zafirlukast—Dermatitis bullous—Capecitabine—esophageal cancer	0.00051	0.0112	CcSEcCtD
Zafirlukast—CYSLTR1—bronchus—esophageal cancer	0.000502	0.128	CbGeAlD
Zafirlukast—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0005	0.0109	CcSEcCtD
Zafirlukast—CYSLTR1—smooth muscle tissue—esophageal cancer	0.000491	0.126	CbGeAlD
Zafirlukast—Liver function test abnormal—Capecitabine—esophageal cancer	0.00045	0.00986	CcSEcCtD
Zafirlukast—Abdominal discomfort—Capecitabine—esophageal cancer	0.000404	0.00885	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—esophageal cancer	0.000404	0.00885	CcSEcCtD
Zafirlukast—Neutropenia—Capecitabine—esophageal cancer	0.000394	0.00863	CcSEcCtD
Zafirlukast—Glyburide—ABCB1—esophageal cancer	0.000386	0.142	CrCbGaD
Zafirlukast—Ill-defined disorder—Cisplatin—esophageal cancer	0.00037	0.0081	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000368	0.00807	CcSEcCtD
Zafirlukast—Jaundice—Capecitabine—esophageal cancer	0.000366	0.00802	CcSEcCtD
Zafirlukast—Malaise—Cisplatin—esophageal cancer	0.000359	0.00787	CcSEcCtD
Zafirlukast—Agranulocytosis—Capecitabine—esophageal cancer	0.000351	0.00768	CcSEcCtD
Zafirlukast—Myalgia—Cisplatin—esophageal cancer	0.000339	0.00743	CcSEcCtD
Zafirlukast—Haemoglobin—Capecitabine—esophageal cancer	0.000339	0.00743	CcSEcCtD
Zafirlukast—Hepatitis—Capecitabine—esophageal cancer	0.000337	0.00739	CcSEcCtD
Zafirlukast—Haemorrhage—Capecitabine—esophageal cancer	0.000337	0.00739	CcSEcCtD
Zafirlukast—Hypoaesthesia—Capecitabine—esophageal cancer	0.000336	0.00735	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—esophageal cancer	0.000335	0.00734	CcSEcCtD
Zafirlukast—Discomfort—Cisplatin—esophageal cancer	0.000335	0.00734	CcSEcCtD
Zafirlukast—Oedema—Cisplatin—esophageal cancer	0.000325	0.00712	CcSEcCtD
Zafirlukast—CYSLTR1—lung—esophageal cancer	0.000324	0.0828	CbGeAlD
Zafirlukast—Infection—Cisplatin—esophageal cancer	0.000323	0.00708	CcSEcCtD
Zafirlukast—Thrombocytopenia—Cisplatin—esophageal cancer	0.000318	0.00697	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—esophageal cancer	0.000311	0.00681	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—esophageal cancer	0.000301	0.00659	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000296	0.00649	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—esophageal cancer	0.000293	0.00643	CcSEcCtD
Zafirlukast—Back pain—Capecitabine—esophageal cancer	0.000284	0.00622	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000281	0.00615	CcSEcCtD
Zafirlukast—Pain—Cisplatin—esophageal cancer	0.000278	0.00609	CcSEcCtD
Zafirlukast—Ill-defined disorder—Capecitabine—esophageal cancer	0.000272	0.00597	CcSEcCtD
Zafirlukast—Feeling abnormal—Cisplatin—esophageal cancer	0.000268	0.00587	CcSEcCtD
Zafirlukast—Malaise—Capecitabine—esophageal cancer	0.000265	0.0058	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—esophageal cancer	0.000261	0.00572	CcSEcCtD
Zafirlukast—Body temperature increased—Cisplatin—esophageal cancer	0.000257	0.00563	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—esophageal cancer	0.000252	0.00553	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—esophageal cancer	0.000251	0.0055	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—esophageal cancer	0.000251	0.0055	CcSEcCtD
Zafirlukast—Myalgia—Capecitabine—esophageal cancer	0.00025	0.00548	CcSEcCtD
Zafirlukast—Arthralgia—Capecitabine—esophageal cancer	0.00025	0.00548	CcSEcCtD
Zafirlukast—Discomfort—Capecitabine—esophageal cancer	0.000247	0.00541	CcSEcCtD
Zafirlukast—Oedema—Capecitabine—esophageal cancer	0.00024	0.00525	CcSEcCtD
Zafirlukast—Hypersensitivity—Cisplatin—esophageal cancer	0.00024	0.00525	CcSEcCtD
Zafirlukast—Infection—Capecitabine—esophageal cancer	0.000238	0.00522	CcSEcCtD
Zafirlukast—Thrombocytopenia—Capecitabine—esophageal cancer	0.000235	0.00514	CcSEcCtD
Zafirlukast—Asthenia—Cisplatin—esophageal cancer	0.000233	0.00511	CcSEcCtD
Zafirlukast—Diarrhoea—Cisplatin—esophageal cancer	0.000222	0.00487	CcSEcCtD
Zafirlukast—CYSLTR1—lymph node—esophageal cancer	0.000221	0.0567	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000218	0.00478	CcSEcCtD
Zafirlukast—Insomnia—Capecitabine—esophageal cancer	0.000217	0.00475	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—esophageal cancer	0.000211	0.00463	CcSEcCtD
Zafirlukast—Dyspepsia—Capecitabine—esophageal cancer	0.000211	0.00462	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000207	0.00453	CcSEcCtD
Zafirlukast—Vomiting—Cisplatin—esophageal cancer	0.000207	0.00453	CcSEcCtD
Zafirlukast—Fatigue—Capecitabine—esophageal cancer	0.000207	0.00453	CcSEcCtD
Zafirlukast—Rash—Cisplatin—esophageal cancer	0.000205	0.00449	CcSEcCtD
Zafirlukast—Pain—Capecitabine—esophageal cancer	0.000205	0.00449	CcSEcCtD
Zafirlukast—Dermatitis—Cisplatin—esophageal cancer	0.000205	0.00449	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—esophageal cancer	0.000203	0.00444	CcSEcCtD
Zafirlukast—Feeling abnormal—Capecitabine—esophageal cancer	0.000198	0.00433	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—esophageal cancer	0.000197	0.00432	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000196	0.00429	CcSEcCtD
Zafirlukast—Nausea—Cisplatin—esophageal cancer	0.000193	0.00423	CcSEcCtD
Zafirlukast—Urticaria—Capecitabine—esophageal cancer	0.00019	0.00417	CcSEcCtD
Zafirlukast—Abdominal pain—Capecitabine—esophageal cancer	0.000189	0.00415	CcSEcCtD
Zafirlukast—Body temperature increased—Capecitabine—esophageal cancer	0.000189	0.00415	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—esophageal cancer	0.000186	0.00408	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—esophageal cancer	0.000186	0.00408	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—esophageal cancer	0.000184	0.00403	CcSEcCtD
Zafirlukast—Infection—Methotrexate—esophageal cancer	0.000177	0.00388	CcSEcCtD
Zafirlukast—Hypersensitivity—Capecitabine—esophageal cancer	0.000177	0.00387	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—esophageal cancer	0.000175	0.00383	CcSEcCtD
Zafirlukast—Asthenia—Capecitabine—esophageal cancer	0.000172	0.00377	CcSEcCtD
Zafirlukast—Pruritus—Capecitabine—esophageal cancer	0.00017	0.00371	CcSEcCtD
Zafirlukast—Diarrhoea—Capecitabine—esophageal cancer	0.000164	0.00359	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000163	0.00356	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—esophageal cancer	0.000161	0.00354	CcSEcCtD
Zafirlukast—Dizziness—Capecitabine—esophageal cancer	0.000158	0.00347	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—esophageal cancer	0.000157	0.00344	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000154	0.00337	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—esophageal cancer	0.000154	0.00337	CcSEcCtD
Zafirlukast—Pain—Methotrexate—esophageal cancer	0.000153	0.00334	CcSEcCtD
Zafirlukast—Vomiting—Capecitabine—esophageal cancer	0.000152	0.00334	CcSEcCtD
Zafirlukast—Rash—Capecitabine—esophageal cancer	0.000151	0.00331	CcSEcCtD
Zafirlukast—Dermatitis—Capecitabine—esophageal cancer	0.000151	0.00331	CcSEcCtD
Zafirlukast—Headache—Capecitabine—esophageal cancer	0.00015	0.00329	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—esophageal cancer	0.000147	0.00322	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000146	0.0032	CcSEcCtD
Zafirlukast—Nausea—Capecitabine—esophageal cancer	0.000142	0.00312	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—esophageal cancer	0.000142	0.00311	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—esophageal cancer	0.000141	0.00309	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—esophageal cancer	0.000141	0.00309	CcSEcCtD
Zafirlukast—CYP2C19—digestive system—esophageal cancer	0.000133	0.0341	CbGeAlD
Zafirlukast—Hypersensitivity—Methotrexate—esophageal cancer	0.000131	0.00288	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—esophageal cancer	0.000128	0.0028	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—esophageal cancer	0.000126	0.00277	CcSEcCtD
Zafirlukast—PTGS1—epithelium—esophageal cancer	0.000124	0.0317	CbGeAlD
Zafirlukast—Diarrhoea—Methotrexate—esophageal cancer	0.000122	0.00267	CcSEcCtD
Zafirlukast—PTGS1—smooth muscle tissue—esophageal cancer	0.000119	0.0305	CbGeAlD
Zafirlukast—Dizziness—Methotrexate—esophageal cancer	0.000118	0.00258	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—esophageal cancer	0.000113	0.00249	CcSEcCtD
Zafirlukast—Rash—Methotrexate—esophageal cancer	0.000112	0.00246	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—esophageal cancer	0.000112	0.00246	CcSEcCtD
Zafirlukast—Headache—Methotrexate—esophageal cancer	0.000112	0.00245	CcSEcCtD
Zafirlukast—PTGS1—trachea—esophageal cancer	0.00011	0.028	CbGeAlD
Zafirlukast—CYP1A2—digestive system—esophageal cancer	0.000109	0.0278	CbGeAlD
Zafirlukast—Nausea—Methotrexate—esophageal cancer	0.000106	0.00232	CcSEcCtD
Zafirlukast—CYP2C9—digestive system—esophageal cancer	0.000103	0.0264	CbGeAlD
Zafirlukast—CYP2E1—digestive system—esophageal cancer	9.78e-05	0.025	CbGeAlD
Zafirlukast—ABCG2—lung—esophageal cancer	9.44e-05	0.0241	CbGeAlD
Zafirlukast—PTGS1—digestive system—esophageal cancer	9.42e-05	0.0241	CbGeAlD
Zafirlukast—CYP1A2—lung—esophageal cancer	9.08e-05	0.0232	CbGeAlD
Zafirlukast—CYP2E1—lung—esophageal cancer	8.17e-05	0.0209	CbGeAlD
Zafirlukast—CYP3A4—digestive system—esophageal cancer	7.87e-05	0.0201	CbGeAlD
Zafirlukast—PTGS1—lung—esophageal cancer	7.87e-05	0.0201	CbGeAlD
Zafirlukast—CYP2D6—digestive system—esophageal cancer	7.74e-05	0.0198	CbGeAlD
Zafirlukast—ABCG2—lymph node—esophageal cancer	6.45e-05	0.0165	CbGeAlD
Zafirlukast—PTGS1—lymph node—esophageal cancer	5.38e-05	0.0138	CbGeAlD
Zafirlukast—ABCG2—Metabolism—PSME1—esophageal cancer	2.49e-05	0.00018	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.44e-05	0.000177	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.43e-05	0.000176	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ENO1—esophageal cancer	2.42e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—esophageal cancer	2.42e-05	0.000175	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—esophageal cancer	2.41e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALDOB—esophageal cancer	2.39e-05	0.000173	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PSME1—esophageal cancer	2.39e-05	0.000173	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PSME2—esophageal cancer	2.39e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMP—esophageal cancer	2.38e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—esophageal cancer	2.36e-05	0.000171	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—esophageal cancer	2.36e-05	0.000171	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.33e-05	0.000169	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADH7—esophageal cancer	2.33e-05	0.000169	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.33e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA1—esophageal cancer	2.33e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.32e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADH7—esophageal cancer	2.31e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.31e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.3e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.29e-05	0.000166	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.28e-05	0.000165	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.26e-05	0.000164	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.23e-05	0.000161	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNG7—esophageal cancer	2.17e-05	0.000157	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.15e-05	0.000156	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TPI1—esophageal cancer	2.15e-05	0.000156	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1B1—esophageal cancer	2.15e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA2—esophageal cancer	2.13e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMP—esophageal cancer	2.13e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.11e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.11e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—esophageal cancer	2.09e-05	0.000151	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.09e-05	0.000151	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.08e-05	0.000151	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.07e-05	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.07e-05	0.00015	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.06e-05	0.000149	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—esophageal cancer	2.05e-05	0.000149	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.05e-05	0.000148	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.03e-05	0.000147	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.03e-05	0.000147	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1A—esophageal cancer	2.02e-05	0.000146	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.02e-05	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.02e-05	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.99e-05	0.000144	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—esophageal cancer	1.98e-05	0.000144	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADH7—esophageal cancer	1.98e-05	0.000143	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.98e-05	0.000143	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.97e-05	0.000143	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMP—esophageal cancer	1.96e-05	0.000142	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.95e-05	0.000142	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMP—esophageal cancer	1.94e-05	0.00014	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.94e-05	0.00014	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.93e-05	0.00014	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.92e-05	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TPI1—esophageal cancer	1.92e-05	0.000139	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EP300—esophageal cancer	1.92e-05	0.000139	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.91e-05	0.000138	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.9e-05	0.000138	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.89e-05	0.000137	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNG7—esophageal cancer	1.87e-05	0.000136	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.85e-05	0.000134	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.84e-05	0.000134	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HMOX1—esophageal cancer	1.84e-05	0.000133	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.84e-05	0.000133	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ENO1—esophageal cancer	1.81e-05	0.000131	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.81e-05	0.000131	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.79e-05	0.00013	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA1—esophageal cancer	1.79e-05	0.00013	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PSME1—esophageal cancer	1.78e-05	0.000129	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PSME2—esophageal cancer	1.78e-05	0.000129	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000129	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.77e-05	0.000128	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TPI1—esophageal cancer	1.77e-05	0.000128	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HMOX1—esophageal cancer	1.77e-05	0.000128	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—esophageal cancer	1.77e-05	0.000128	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.76e-05	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.76e-05	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.75e-05	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TPI1—esophageal cancer	1.75e-05	0.000127	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.73e-05	0.000126	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.73e-05	0.000126	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—esophageal cancer	1.7e-05	0.000123	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.7e-05	0.000123	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.68e-05	0.000122	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—esophageal cancer	1.67e-05	0.000121	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNG7—esophageal cancer	1.67e-05	0.000121	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.67e-05	0.000121	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMP—esophageal cancer	1.66e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.65e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.65e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA2—esophageal cancer	1.64e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—esophageal cancer	1.64e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.63e-05	0.000118	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.62e-05	0.000117	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.62e-05	0.000117	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.61e-05	0.000117	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.6e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.57e-05	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.57e-05	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ENO1—esophageal cancer	1.57e-05	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.57e-05	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PSME2—esophageal cancer	1.54e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PSME1—esophageal cancer	1.54e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.54e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNG7—esophageal cancer	1.54e-05	0.000111	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADH7—esophageal cancer	1.53e-05	0.000111	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.53e-05	0.000111	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNG7—esophageal cancer	1.53e-05	0.00011	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.5e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TPI1—esophageal cancer	1.5e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.49e-05	0.000108	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.47e-05	0.000107	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.47e-05	0.000106	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.45e-05	0.000105	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.44e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.44e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.43e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—esophageal cancer	1.42e-05	0.000103	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.4e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ENO1—esophageal cancer	1.4e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.38e-05	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PSME2—esophageal cancer	1.38e-05	9.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PSME1—esophageal cancer	1.38e-05	9.97e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—esophageal cancer	1.38e-05	9.96e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.37e-05	9.93e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.37e-05	9.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.36e-05	9.85e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.36e-05	9.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.35e-05	9.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.34e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.34e-05	9.69e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.34e-05	9.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.33e-05	9.64e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.32e-05	9.57e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNG7—esophageal cancer	1.3e-05	9.44e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO1—esophageal cancer	1.29e-05	9.31e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.29e-05	9.31e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.28e-05	9.29e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMP—esophageal cancer	1.28e-05	9.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.27e-05	9.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO1—esophageal cancer	1.27e-05	9.23e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.27e-05	9.18e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PSME1—esophageal cancer	1.27e-05	9.17e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PSME2—esophageal cancer	1.27e-05	9.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PSME2—esophageal cancer	1.26e-05	9.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PSME1—esophageal cancer	1.26e-05	9.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.25e-05	9.06e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.24e-05	9.01e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.22e-05	8.85e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.21e-05	8.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.2e-05	8.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.19e-05	8.6e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CREBBP—esophageal cancer	1.18e-05	8.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.16e-05	8.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TPI1—esophageal cancer	1.16e-05	8.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.16e-05	8.37e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.14e-05	8.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.14e-05	8.27e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CREBBP—esophageal cancer	1.13e-05	8.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.12e-05	8.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.12e-05	8.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.11e-05	8.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.09e-05	7.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.09e-05	7.88e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO1—esophageal cancer	1.09e-05	7.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.08e-05	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSME2—esophageal cancer	1.07e-05	7.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSME1—esophageal cancer	1.07e-05	7.77e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.07e-05	7.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.06e-05	7.66e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—esophageal cancer	1.06e-05	7.65e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.03e-05	7.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.02e-05	7.38e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.02e-05	7.38e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—esophageal cancer	1.02e-05	7.35e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNG7—esophageal cancer	1.01e-05	7.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1e-05	7.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—esophageal cancer	9.78e-06	7.09e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—esophageal cancer	9.67e-06	7e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDH2—esophageal cancer	9.43e-06	6.83e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—esophageal cancer	9.38e-06	6.79e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.37e-06	6.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.3e-06	6.73e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—esophageal cancer	9.29e-06	6.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1B1—esophageal cancer	9.26e-06	6.7e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.12e-06	6.6e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—esophageal cancer	9e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.97e-06	6.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.92e-06	6.46e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.86e-06	6.42e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP19A1—esophageal cancer	8.7e-06	6.3e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CREBBP—esophageal cancer	8.48e-06	6.14e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO1—esophageal cancer	8.4e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.4e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.29e-06	6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSME2—esophageal cancer	8.28e-06	6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSME1—esophageal cancer	8.28e-06	6e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—esophageal cancer	8.04e-06	5.82e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—esophageal cancer	7.94e-06	5.75e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.79e-06	5.64e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—esophageal cancer	7.72e-06	5.59e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—esophageal cancer	7.62e-06	5.52e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—esophageal cancer	7.59e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.4e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CREBBP—esophageal cancer	7.33e-06	5.31e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.15e-06	5.17e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—esophageal cancer	6.94e-06	5.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.75e-06	4.88e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.72e-06	4.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—esophageal cancer	6.56e-06	4.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.54e-06	4.74e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.13e-06	4.44e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CREBBP—esophageal cancer	6.01e-06	4.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—esophageal cancer	6e-06	4.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.96e-06	4.32e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—esophageal cancer	5.95e-06	4.31e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.88e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—esophageal cancer	5.86e-06	4.24e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—esophageal cancer	5.77e-06	4.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.76e-06	4.17e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—esophageal cancer	5.71e-06	4.14e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—esophageal cancer	5.39e-06	3.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.36e-06	3.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—esophageal cancer	5.34e-06	3.87e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.1e-06	3.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—esophageal cancer	4.99e-06	3.61e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.93e-06	3.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.88e-06	3.54e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—esophageal cancer	4.56e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—esophageal cancer	4.45e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.27e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.17e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—esophageal cancer	4.1e-06	2.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—esophageal cancer	4.06e-06	2.94e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.93e-06	2.85e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.69e-06	2.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—esophageal cancer	3.52e-06	2.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—esophageal cancer	3.47e-06	2.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.29e-06	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.22e-06	2.33e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.03e-06	2.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3e-06	2.18e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—esophageal cancer	2.68e-06	1.94e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.57e-06	1.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.98e-06	1.43e-05	CbGpPWpGaD
